Misra Lopa, Khurmi Narjeet, Trentman Terrence L
Department of Anesthesiology, Mayo Clinic Arizona, Phoenix, AZ 85054, USA.
Indian J Anaesth. 2016 Aug;60(8):534-41. doi: 10.4103/0019-5049.187776.
Angioedema is a rare condition which manifests as sudden localised, non-pitting swelling of certain body parts including skin and mucous membranes. It is vital that anaesthesiologists understand this condition, as it may present suddenly in the perioperative period with airway compromise. To identify literature for this review, the authors searched the PubMed, Medline, Embase, Scopus and Web of Science databases for English language articles covering a 10-year period, 2006 through 2016. Angioedema can be either mast-cell mediated or bradykinin-induced. Older therapies for histaminergic symptoms are well known to anaesthesiologists (e.g., adrenaline, anti-histamines and steroids), whereas older therapies for bradykinin-induced symptoms include plasma and attenuated androgens. New classes of drugs for bradykinin-induced symptoms are now available, including anti-bradykinin, plasma kallikrein inhibitor and C1 esterase inhibitors. These can be used prophylactically or as rescue medications. Anaesthesiologists are in a unique position to coordinate perioperative care for this complex group of patients.
血管性水肿是一种罕见病症,表现为身体某些部位(包括皮肤和黏膜)突然出现局限性、非凹陷性肿胀。麻醉医生了解这种病症至关重要,因为它可能在围手术期突然出现并导致气道受压。为了查找本次综述的文献,作者在PubMed、Medline、Embase、Scopus和科学网数据库中搜索了2006年至2016年这10年间的英文文章。血管性水肿可以是肥大细胞介导的,也可以是缓激肽诱导的。麻醉医生熟知治疗组胺能症状的传统疗法(如肾上腺素、抗组胺药和类固醇),而治疗缓激肽诱导症状的传统疗法包括血浆和减毒雄激素。现在有了治疗缓激肽诱导症状的新型药物类别,包括抗缓激肽、血浆激肽释放酶抑制剂和C1酯酶抑制剂。这些药物可用于预防性治疗或作为急救药物。麻醉医生在协调这类复杂患者的围手术期护理方面具有独特地位。